Cargando…
PRR11 in Malignancies: Biological Activities and Targeted Therapies
Proline rich 11 (PRR11), initially renowned for its relevance with cell-cycle progression, is a proline-rich protein coding gene in chromosome 17q22-23. Currently, accumulating studies have demonstrated that PRR11 plays a critical role in cellular proliferation, colony formation, migration, invasion...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775115/ https://www.ncbi.nlm.nih.gov/pubmed/36551227 http://dx.doi.org/10.3390/biom12121800 |
_version_ | 1784855564769034240 |
---|---|
author | Han, Wei Chen, Liang |
author_facet | Han, Wei Chen, Liang |
author_sort | Han, Wei |
collection | PubMed |
description | Proline rich 11 (PRR11), initially renowned for its relevance with cell-cycle progression, is a proline-rich protein coding gene in chromosome 17q22-23. Currently, accumulating studies have demonstrated that PRR11 plays a critical role in cellular proliferation, colony formation, migration, invasion, cell-cycle progression, apoptosis, autophagy and chemotherapy resistance via multiple signaling pathways and biological molecules in several solid tumors. In particular, PRR11 also serves as a promising prognostic indicator in a limited number of human cancers, gradually manifesting its potential application for targeted therapies. In this review, we summarize functional activities, related signaling pathways and biological molecules of PRR11 in various malignancies and generalize potential application of PRR11 for targeted therapies, thereby contributing to further exploration of PRR11 in cancer treatment. |
format | Online Article Text |
id | pubmed-9775115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97751152022-12-23 PRR11 in Malignancies: Biological Activities and Targeted Therapies Han, Wei Chen, Liang Biomolecules Review Proline rich 11 (PRR11), initially renowned for its relevance with cell-cycle progression, is a proline-rich protein coding gene in chromosome 17q22-23. Currently, accumulating studies have demonstrated that PRR11 plays a critical role in cellular proliferation, colony formation, migration, invasion, cell-cycle progression, apoptosis, autophagy and chemotherapy resistance via multiple signaling pathways and biological molecules in several solid tumors. In particular, PRR11 also serves as a promising prognostic indicator in a limited number of human cancers, gradually manifesting its potential application for targeted therapies. In this review, we summarize functional activities, related signaling pathways and biological molecules of PRR11 in various malignancies and generalize potential application of PRR11 for targeted therapies, thereby contributing to further exploration of PRR11 in cancer treatment. MDPI 2022-12-01 /pmc/articles/PMC9775115/ /pubmed/36551227 http://dx.doi.org/10.3390/biom12121800 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Han, Wei Chen, Liang PRR11 in Malignancies: Biological Activities and Targeted Therapies |
title | PRR11 in Malignancies: Biological Activities and Targeted Therapies |
title_full | PRR11 in Malignancies: Biological Activities and Targeted Therapies |
title_fullStr | PRR11 in Malignancies: Biological Activities and Targeted Therapies |
title_full_unstemmed | PRR11 in Malignancies: Biological Activities and Targeted Therapies |
title_short | PRR11 in Malignancies: Biological Activities and Targeted Therapies |
title_sort | prr11 in malignancies: biological activities and targeted therapies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775115/ https://www.ncbi.nlm.nih.gov/pubmed/36551227 http://dx.doi.org/10.3390/biom12121800 |
work_keys_str_mv | AT hanwei prr11inmalignanciesbiologicalactivitiesandtargetedtherapies AT chenliang prr11inmalignanciesbiologicalactivitiesandtargetedtherapies |